BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wu ZX, Yang Y, Zeng L, Patel H, Bo L, Lin L, Chen ZS. Establishment and Characterization of an Irinotecan-Resistant Human Colon Cancer Cell Line. Front Oncol 2020;10:624954. [PMID: 33692943 DOI: 10.3389/fonc.2020.624954] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Szemitko M, Golubinska-Szemitko E, Sienko J, Falkowski A, Wiernicki I. Efficacy of Liver Chemoembolization after Prior Cetuximab Monotherapy in Patients with Metastatic Colorectal Cancer. Cancers (Basel) 2023;15. [PMID: 36672489 DOI: 10.3390/cancers15020541] [Reference Citation Analysis]
2 Morshneva AV, Gnedina OO, Kindt DN, Igotti MV. Establishment and Characterization of Human Colon-Cancer Cells Resistant to Cisplatin. Cell Tiss Biol 2022;16:547-554. [DOI: 10.1134/s1990519x22060037] [Reference Citation Analysis]
3 Kryczka J, Boncela J. Integrated Bioinformatics Analysis of the Hub Genes Involved in Irinotecan Resistance in Colorectal Cancer. Biomedicines 2022;10:1720. [DOI: 10.3390/biomedicines10071720] [Reference Citation Analysis]
4 Yang B, Yan Y, Wang D, Zhang Y, Yin J, Zhu G. On-target inhibition of Cryptosporidium parvum by nitazoxanide (NTZ) and paclitaxel (PTX) validated using a novel MDR1-transgenic host cell model and algorithms to quantify on/off-target rates.. [DOI: 10.1101/2022.06.19.496759] [Reference Citation Analysis]
5 Lin X, Kong D, Chen ZS. Editorial: Chemo-Radiation-Resistance in Cancer Therapy. Front Pharmacol 2022;13:904063. [PMID: 35662703 DOI: 10.3389/fphar.2022.904063] [Reference Citation Analysis]
6 Ozawa S, Miura T, Terashima J, Habano W. Cellular irinotecan resistance in colorectal cancer and overcoming irinotecan refractoriness through various combination trials including DNA methyltransferase inhibitors: a review. Cancer Drug Resist 2021;4:946-64. [PMID: 35582377 DOI: 10.20517/cdr.2021.82] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Wu ZX, Yang Y, Wang JQ, Narayanan S, Lei ZN, Teng QX, Zeng L, Chen ZS. Overexpression of ABCG2 Confers Resistance to MLN7243, a Ubiquitin-Activating Enzyme (UAE) Inhibitor. Front Cell Dev Biol 2021;9:697927. [PMID: 34336849 DOI: 10.3389/fcell.2021.697927] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
8 An Y, Zhao J. Functionalized Selenium Nanotherapeutics Synergizes With Zoledronic Acid to Suppress Prostate Cancer Cell Growth Through Induction of Mitochondria-Mediated Apoptosis and Cell Cycle S Phase Arrest. Front Oncol 2021;11:685784. [PMID: 34168998 DOI: 10.3389/fonc.2021.685784] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]